Search research articles
Contact Us
Filters
Showing results (11-20 of 179) with videos related to
Page
of 18
Sort By:
Hypertension (Dallas, Tex. : 1979)
|
May 28, 2009
Implementation of pay for performance policy in England
Emanuela Falaschetti, Norm R C Campbell, Sailesh Mohan, et al.
Health Technology Assessment (Winchester, England)
|
August 5, 2016
An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo-controlled trial (AARDVARK)
Gaia Kiru, Colin Bicknell, Emanuela Falaschetti, et al.
Clinical Endocrinology
|
May 18, 2011
Improving lipid profiles and increasing use of lipid-lowering therapy in England: results from a national cross-sectional survey - 2006
Jennifer Mindell, Maria Aresu, Paola Zaninotto, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC
|
January 27, 2025
Community pharmacy-based hypertension screening: May Measurement Month 2023 in 3 Canadian provinces
Stephanie C Gysel, Tiffany A Lee, Neil Poulter, et al.
Pharmacoepidemiology and Drug Safety
|
September 5, 2019
Effectiveness of two-drug therapy versus monotherapy as initial regimen in hypertension: A propensity score-matched cohort study in the UK Clinical Practice Research Datalink
Karine Marinier, Pauline Macouillard, Martine de Champvallins, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
November 4, 2006
Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. A mini-symposium held at the British Hypertension Society Meeting, September 2005
Neil Poulter, Alan D Hughes, Bryan Williams, et al.
Medicine
|
May 19, 2025
Insights from the 2023 May measurement month campaign in Newfoundland and Labrador, Canada: A cross-sectional study
Stephen D Coombs, Ross T Tsuyuki, Stephanie W Young, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 14, 2006
Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy
Peter Lindgren, Thomas Kahan, Neil Poulter, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 23, 2016
Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study
Alison Hayes, Hisatomi Arima, Mark Woodward, et al.
Journal of Hypertension
|
January 27, 2011
Issues in the development of new combinations of blood pressure lowering drugs
John Chalmers, Stephen Harrap, Krzysztof Narkiewicz, et al.
Page
of 18
Search research articles
Search
Showing results (11-20 of 179) with videos related to
Sort By:
Page
of 18
Hypertension (Dallas, Tex. : 1979)
|
May 28, 2009
Implementation of pay for performance policy in England
Emanuela Falaschetti, Norm R C Campbell, Sailesh Mohan, et al.
Health Technology Assessment (Winchester, England)
|
August 5, 2016
An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo-controlled trial (AARDVARK)
Gaia Kiru, Colin Bicknell, Emanuela Falaschetti, et al.
Clinical Endocrinology
|
May 18, 2011
Improving lipid profiles and increasing use of lipid-lowering therapy in England: results from a national cross-sectional survey - 2006
Jennifer Mindell, Maria Aresu, Paola Zaninotto, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC
|
January 27, 2025
Community pharmacy-based hypertension screening: May Measurement Month 2023 in 3 Canadian provinces
Stephanie C Gysel, Tiffany A Lee, Neil Poulter, et al.
Pharmacoepidemiology and Drug Safety
|
September 5, 2019
Effectiveness of two-drug therapy versus monotherapy as initial regimen in hypertension: A propensity score-matched cohort study in the UK Clinical Practice Research Datalink
Karine Marinier, Pauline Macouillard, Martine de Champvallins, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
November 4, 2006
Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. A mini-symposium held at the British Hypertension Society Meeting, September 2005
Neil Poulter, Alan D Hughes, Bryan Williams, et al.
Medicine
|
May 19, 2025
Insights from the 2023 May measurement month campaign in Newfoundland and Labrador, Canada: A cross-sectional study
Stephen D Coombs, Ross T Tsuyuki, Stephanie W Young, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 14, 2006
Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy
Peter Lindgren, Thomas Kahan, Neil Poulter, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 23, 2016
Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study
Alison Hayes, Hisatomi Arima, Mark Woodward, et al.
Journal of Hypertension
|
January 27, 2011
Issues in the development of new combinations of blood pressure lowering drugs
John Chalmers, Stephen Harrap, Krzysztof Narkiewicz, et al.
Page
of 18